Pharmaceutical Companies

Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.

Published in Pharma Business Week, July 30th, 2012

2012 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Human Genome Sciences, Inc. ("Human Genome" or the "Company") (Nasdaq- HGSI) relating to the proposed acquisition by GlaxoSmithKline plc. ("GSK").

Under the terms of the transaction, Human Genome shareholders will receive only $14.25 in cash for each of Human Genome stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Human Genome for not acting in the Company's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Business Week

Source: Pharma Business Week (2012-07-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry